Management of Cardiovascular Health Issues in Turner Syndrome: Expert Insights and Expanded Recommendations From the 2024 Guideline Development Team
American Journal of Medical Genetics Part C: Seminars in Medical Genetics · 2025-06 · 199 (2) · 51-71
DOI: 10.1002/ajmg.c.32139 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift American Journal of Medical Genetics Part C: Seminars in Medical Genetics, online erschienen am 26.03.2025. Verfasst von Katya de Groote und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Cardiology, Ghent University Hospital, Ghent, Belgium. Hauptthemen laut MEDLINE: Turner Syndrome, Heart Defects, Congenital, Cardiovascular Diseases. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 161 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Turner syndrome (TS) is frequently complicated by congenital heart disease (CHD). While left‐sided lesions such as bicuspid aortic valve (BAV) and coarctation of the aorta are the most common structural heart lesions in TS, other anomalies, such as aortic arch malformations, hypoplastic left heart syndrome (HLHS), persistent left superior vena cava (LSVC), and partial anomalous pulmonary venous return (PAPVR), are also relatively frequent. Standardized mortality is increased threefold in individuals with TS compared to the general population, with cardiovascular complications, including aortic dissection, being the leading cause of death. The publication of the 2024 Clinical Practice Guidelines for TS marks an important opportunity to remind clinicians about the burden of congenital heart and vascular lesions in TS and the need for lifelong cardiovascular surveillance. In this expert panel statement, we will focus on the rationale for clinical management of CHD in TS, emphasizing TS‐specific features of CHD that influence clinical decision making about therapeutic options and follow‐up care.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pediatric Cardiology, Ghent University Hospital, Ghent, Belgium.
- Fetal Cardiac Program, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
- Cardiorespiratory Unit, Great Ormond Street Hospital for Children, London, UK.
- St. Paul's Hospital, University of British Columbia, Vancouver, British Columbia, Canada.
- Department of Cardiology, Radboud University Medical Center, Nijmegen, the Netherlands.
- Department of Pediatrics, University of Cincinnati, Cincinnati, Ohio, USA.
ORCID-Profile: Anthonie Duijnhouwer, Siddharth K Prakash
Zitieren
APA
de Groote, K., Patel, S. R., Mortensen, K. H., Witvrouwen, I., Duijnhouwer, A., Brown, N. M., Grewal, J., Chatfield, K. C., Dorfman, A. T., & Prakash, S. K. (2025). Management of Cardiovascular Health Issues in Turner Syndrome: Expert Insights and Expanded Recommendations From the 2024 Guideline Development Team. American Journal of Medical Genetics Part C: Seminars in Medical Genetics, 199(2), 51-71. https://doi.org/10.1002/ajmg.c.32139
Vancouver
de Groote K, Patel SR, Mortensen KH, Witvrouwen I, Duijnhouwer A, Brown NM, et al. Management of Cardiovascular Health Issues in Turner Syndrome: Expert Insights and Expanded Recommendations From the 2024 Guideline Development Team. American Journal of Medical Genetics Part C: Seminars in Medical Genetics. 2025;199(2):51-71. doi:10.1002/ajmg.c.32139
BibTeX
@article{deGroote2025,
author = {de Groote, Katya and Patel, Sheetal R and Mortensen, Kristian Havmand and Witvrouwen, Isabel and Duijnhouwer, Anthonie and Brown, Nicole M and Grewal, Jasmine and Chatfield, Kathryn C and Dorfman, Aaron T and Prakash, Siddharth K},
title = {Management of Cardiovascular Health Issues in Turner Syndrome: Expert Insights and Expanded Recommendations From the 2024 Guideline Development Team},
journal = {American Journal of Medical Genetics Part C: Seminars in Medical Genetics},
year = {2025},
volume = {199},
number = {2},
pages = {51--71},
doi = {10.1002/ajmg.c.32139}
}
EUVIMED